Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C548651 |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of NETO2 mRNA | decreases expression | 19933214
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene results in increased expression of NETO2 mRNA | increases expression | 20406850
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of NETO2 mRNA | decreases expression | 20382639 19150397
|
D004041 |
Dietary Fats |
Dietary Fats results in increased expression of NETO2 mRNA | increases expression | 18042831
|
D005472 |
Fluorouracil |
NETO2 protein affects the susceptibility to Fluorouracil | affects response to substance | 16217747
|
C041786 |
palm oil |
palm oil results in increased expression of NETO2 mRNA | increases expression | 18042831
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of NETO2 mRNA | decreases expression | 19933214
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of NETO2 mRNA | increases expression | 19465110
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.24 | 11752688 15322242 14514962 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
2.48 | 17638652 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.77 | 16835633 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
9.58 | 17963324 15504547 16511603 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
9.58 | 11748828 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
4.25 | 15238619 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.33 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.23 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.93 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
1.86 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
1.86 | 16110121 15136595 18357371 19217205 16557594 16595493 18608205 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.86 | 20435547 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
5.11 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
8.94 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
8.94 | 16835633 |
MESH:D003528 |
Carcinoma, Adenoid Cystic |
marker/mechanism |
|
| 16762588 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
3.19 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
3.19 | 17088986 16332177 17971768 16799960 18930000 17045692 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
3.13 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
2.55 | 18986760 16757204 16280240 17066447 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.50 | 18850075 18670907 16120746 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
7.26 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7.26 | 20889678 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.41 | 16835633 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.20 | 8697196 12621046 16354765 15668235 15340226 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
2.27 | 17172411 17725105 17169374 16510598 17287894 15001691 18772588 16340194 17016597 17018589 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
2.00 | 18288408 15148649 18949393 16303861 17255274 16331619 16391804 14970324 18448328 17401013 17594712 20501625 17016601 17454858 17094418 17695437 16282729 16524972 15289873 18802399 18383874 18509181 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.31 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 10048152 20055451 15322242 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.38 | 18551238 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
5.19 | 16733453 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.72 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
3.92 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.92 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.96 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.65 | 18367378 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.65 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.35 | 18230668 16714409 15322242 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.29 | 9294722 10568697 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.71 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
4.71 | 15173087 16337965 17638652 16481741 16785472 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.21 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
3.52 | 19551842 17967931 18296743 19004024 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.81 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
9.84 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
9.84 | 20067830 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
2.96 | 16145905 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
5.04 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
3.56 | 18337622 15102660 15162350 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.46 | 10048152 11294989 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.62 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.25 | 15340226 16120746 12621046 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.49 | 15340226 8697196 16959395 16354765 18606429 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.87 | 21332399 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.92 | 21332399 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.99 | 18850075 18670907 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
5.34 | 20412841 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.34 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
3.27 | 18457598 11836018 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.62 | 16580747 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
8.27 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
8.27 | 16985049 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
3.01 | 18296743 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
1.24 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
7.94 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
7.94 | 18383874 15113037 16603448 17045692 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.94 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
6.27 | 2876784 6135515 2876786 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
6.27 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
2.41 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.41 | 11884234 19555203 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
5.19 | 15086387 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
3.84 | 16757204 18986760 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.24 | 12213967 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
4.26 | 7678174 18551238 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
2.72 | 16928823 18600527 18239605 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.54 | 14600291 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.61 | 16436463 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
2.34 | 18674790 20132043 21332399 16723640 20518802 18457598 17217161 19632207 11836018 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.70 | 16049721 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
2.74 | 16929163 19003803 15113037 16500647 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.69 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.89 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.59 | 11222880 11118676 11399792 11896295 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
3.37 | 19082440 18626508 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
4.26 | 16160472 18722050 18286688 15538739 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.17 | 18990726 |
MESH:D012468 |
Salivary Gland Neoplasms |
marker/mechanism |
|
| 16762588 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.71 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.15 | 16192470 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
2.00 | 16424979 18567086 17522103 19015929 17498489 18396642 17172411 15786421 16951190 19084572 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.35 | 12697716 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
4.25 | 16280240 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
2.38 | 16049721 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.71 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
4.14 | 16803524 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
5.04 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.69 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.99 | 16723640 |